Medication info
Pimadipine Tablet 60/2.5 mg (Pimasartan Potassium, Amlodipine)

Pimadipine Tablet 60/2.5 mg (Pimasartan Potassium, Amlodipine)

Prescription medicationTabletOral
Ingredient · strength
S-Amlodipine Besylate Dihydrate›3.69mg / 1 tabletFimasartan Potassium Trihydrate›66.01mg / 1 tablet
Manufacturer / importer
Shinpoong Pharmaceutical Co., Ltd.
Appearance
Yellow, round, square-shaped film-coated tablet
Packaging
Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle
Approval status
Active

MFDS item code 202204662 · Approved 2022.12.27 · Insurance code 648508080

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan potassium monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dosage adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dosage adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Ingredients

Manufacturer
Shinpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan potassium monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy using Pimasartan Potassium. In other words, this drug helps to effectively lower blood pressure to manage hypertension.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dosage adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dosage adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. People with allergies to this medication or similar class medications, pregnant or breastfeeding individuals, patients undergoing kidney dialysis, patients with severe liver impairment, patients with biliary obstruction, diabetic patients with certain kidney diseases, and patients with specific genetic metabolic disorders should not take this medication. Patients with low blood volume or sodium deficiency, patients with impaired kidney function, patients with renovascular hypertension, patients with aortic or heart valve diseases, patients with severe hypotension, and elderly individuals should take this medication with special caution. Side effects such as dizziness, headache, facial or limb swelling, urinary disorders, insomnia, and flushing may occur when taking this medication, so it is important to consult healthcare professionals if these symptoms arise. Low blood pressure may occur at the beginning of treatment, so especially patients on diuretics or those with decreased blood volume should be closely monitored. This medication may interact with other drugs, so it is essential to inform healthcare professionals of any current medications, especially when taken in combination with potassium supplements, diuretics, lithium, and non-steroidal anti-inflammatory drugs. During pregnancy, it should be avoided as it may pose risks to the fetus, and during breastfeeding, it is recommended to either stop breastfeeding or discontinue medication as the drug may pass into breast milk. The safety and efficacy in children under 18 years old have not been established, so it is advisable to avoid use in this age group. In case of overdose, symptoms such as hypotension, arrhythmias, and shock may occur, requiring immediate emergency treatment, and appropriate measures should be taken following healthcare professional instructions. This medication should be stored out of reach of children and not transferred to other containers for safety, and caution should be exercised when driving or operating hazardous machinery while taking the medication.

Side effects

Dizziness, orthostatic dizziness, headache, facial edema, peripheral edema, urination disorders, insomnia, flushing, syncope, sedation, migraine, dyspepsia, vomiting, nausea, upper abdominal pain, weakness, foreign body sensation, elevated liver enzyme levels, decreased platelet count, increased serum creatine phosphokinase, cough, muscle contraction, musculoskeletal stiffness, itching, localized urticaria, facial flushing, erectile dysfunction, epilepsy, amyotrophic lateral sclerosis, neuropathy, neuronitis, facial paralysis, normal pressure hydrocephalus, spinal canal stenosis, acute pancreatitis, intestinal obstruction, hemorrhagic duodenal ulcer, appendicitis, hemorrhoids, abdominal pain, intracranial hemorrhage, transient ischemic attack, atherosclerosis, exacerbation of cerebral ischemia, cerebral hemorrhage, liver cancer, colon cancer, unspecified neoplasm, cervical cancer, prostate cancer, acute renal failure, chronic renal failure, kidney stones, pyelonephritis, urinary incontinence, rhinitis, interstitial pneumonia, pharyngitis, pneumonia, pulmonary disease, death, exacerbation of low back pain, osteoarthritis, arthritis, hypoglycemia, hyperkalemia, pulmonary embolism, purpura, bradycardia, atrial fibrillation, coronary artery disease, aortic stenosis, heart failure, increased blood pressure, acute hepatitis, benign pituitary neoplasm, otitis media, uterine prolapse, recurrent cancer, chest pain, weakness, fatigue, pain, weight gain, weight loss, hypotension, vasculitis, increased tension, sensory impairment, dysesthesia, peripheral neuropathy, taste disorders, tremor, extrapyramidal disorders, gynecomastia, changes in bowel habits, dry mouth, dyspepsia, gingival hyperplasia, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, dyspnea, hair loss, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, nocturia, hepatitis, jaundice, elevated liver enzyme levels, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, thoracic pain, hypotension, sinoatrial block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, skin erythema, maculopapular rash, heaviness, heat sensation, decreased glucose tolerance, weakness, symptoms of hypotension due to depletion of blood volume and/or sodium, hyperkalemia, increased serum creatinine, increased blood urea nitrogen, acute renal failure, changes in renal function, blood pressure reduction, shock symptoms, loss of consciousness, dyspnea, severe hypotension, pulmonary edema, drowsiness when taking antihypertensives, pulmonary edema, increased blood pressure, blood pressure variability, increased blood pressure

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container that blocks light and prevents air infiltration. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow, round, square-shaped film-coated tablet

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.